EFFECT OF CAPTOPRIL ON RENAL-FUNCTION IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：18

作者：

PALLA, R

MARCHITIELLO, ME

SASSANO, P

SALVETTI, A

机构：

[1] UNIV PISA, MED GEN CLIN 1, I-56100 PISA, ITALY

[2] UNIV PISA, MED GEN CLIN 2, I-56100 PISA, ITALY

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1982年 / 49卷 / 06期

关键词：

D O I：

10.1016/0002-9149(82)90396-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1577 / 1579

页数：3

共 12 条

[1]

AMANN FW, 1980, LANCET, V1, P150

[2]

ARQUENBOURG PC, 1975, IMMUNOELECTROPHORESI, P8

[3]

BONINI PA, 1970, CLIN CHIM ACTA, V27, P15

[4] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

[5] CLINICAL USE OF AN ORALLY ACTING CONVERTING ENZYME-INHIBITOR - CAPTOPRIL [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

TEXTOR, SC ;

TURINI, GA ;

WAUTERS, JP .

HYPERTENSION, 1980, 2 (04) :558-566

[6] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].

CASE, DB ;

ATLAS, SA ;

LARAGH, JH ;

SEALEY, JE ;

SULLIVAN, PA ;

MCKINSTRY, DN .

PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206

[7] REVERSIBLE RENAL-FAILURE DURING TREATMENT WITH CAPTOPRIL [J].

FARROW, PR ;

WILKINSON, R .

BRITISH MEDICAL JOURNAL, 1979, 1 (6179) :1680-1680

[8]

GUARNIERI F, 1978, ENZYMES HLTH DISEASE, P193

[9]

PRINS EJL, 1979, LANCET, V2, P306

[10] STUDY OF URINARY + SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE [J].

PROCKOP, DJ ;

DAVIDSON, WD .

NEW ENGLAND JOURNAL OF MEDICINE, 1964, 270 (06) :269-&

← 1 2 →